Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Carl Zeiss Meditec AG CZMWF OTC

Other OTC • Healthcare • Medical - Instruments & Supplies • DE • USD

SharesGrow Score
70/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Carl Zeiss Meditec AG (CZMWF) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $31.83. It has a SharesGrow Score of 68/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Financials: revenue is $2.2B, +5.5%/yr average growth. Net income is $141M, growing at -20.2%/yr. Net profit margin is 6.3% (thin). Gross margin is 52.8% (-6.5 pp trend).

Balance sheet: total debt is $132M against $2.1B equity (Debt-to-Equity (D/E) ratio 0.06, conservative). Current ratio is 2.34 (strong liquidity). Debt-to-assets is 3.9%. Total assets: $3.4B.

SharesGrow 7-Criteria breakdown: Value 75/100 (Pass), Growth 40/100 (Partial), Past 100/100 (Pass), Health 100/100 (Pass), Moat 59/100 (Partial), Future ?/100 (Fail), Income 45/100 (Partial).

CZMWF SharesGrow Score Overview

70/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 75/100
Valuation — P/E, PEG, Forward PEG
GROWTH 40/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 59/100
Gross margin is + market cap
FUTURE 0/100
Analyst outlook — as buy
INCOME 45/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CZMWF

✓
VALUE Pass
75/100
CZMWF trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
~
GROWTH Partial
40/100
CZMWF: +5.5%/yr revenue is, -20.2%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
✓
PAST Pass
100/100
CZMWF: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
✓
HEALTH Pass
100/100
Balance sheet CZMWF: Debt-to-Equity (D/E) ratio 0.06 (conservative), Current ratio is 2.34 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
~
MOAT Partial
59/100
CZMWF: Gross margin is 52.8% (-6.5 pp trend), $3B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 59/100. ≥ 70 = Pass.
View details →
—
FUTURE N/A
N/A
No analyst coverage available for this stock.
~
INCOME Partial
45/100
CZMWF: Net profit margin is 6.3%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range26.42-70.88
Volume150
Avg Volume (30D)71
Market Cap$2.79B
Beta (1Y)1.34
Dividend Yield$0.4659
Share Statistics
EPS (TTM)1.61
Shares Outstanding$87.54M
IPO Date2012-03-14
Employees2,066
CEOAndreas Pecher
Financial Highlights & Ratios
Revenue (TTM)$2.23B
Gross Profit$1.18B
EBITDA$407M
Net Income$141.21M
Operating Income$223.32M
Total Cash$27.27M
Total Debt$132.46M
Net Debt$105.19M
Total Assets$3.4B
Price / Earnings (P/E)19.8
Price / Sales (P/S)1.25
Analyst Forecast
Company Info
CountryDE
ExchangeOther OTC
CurrencyUSD
ISINDE0005313704

Price Chart

Track all markets on TradingView
CZMWF
Carl Zeiss Meditec AG ↗  ·  Other OTC
Healthcare • Medical - Instruments & Supplies
26.42 52WK RANGE 70.88

People Also View

ESLOF
ESLOF
EssilorLuxottica SA
$243.20
+1.64%
 HOCPF
HOCPF
HOYA Corporation
$185.00
+3.20%
 SAUHF
SAUHF
Straumann Holding AG
$115.85
+10.39%
 CLPBF
CLPBF
Coloplast A/S
$65.31
+0.00%
 CZMWY
CZMWY
Carl Zeiss Meditec AG
$32.29
+1.38%
 LLY
LLY
Eli Lilly and Company
$905.13
-1.88%
 JNJ
JNJ
Johnson & Johnson
$238.67
-0.60%
 ABBV
ABBV
AbbVie Inc.
$208.43
-0.87%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message